Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.09.2019 | Case report

Cytarabine/daunorubicin

Ecthyma gangernusom secondary to Escherichia coli bacteraemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 45-year-old woman developed ecthyma gangernusom secondary to Escherichia coli bacteraemia following treatment with cytarabine and daunorubicin for acute myeloid leukaemia. …
Literatur
Zurück zum Zitat Salehi M, et al. Ecthyma gangrenosum due to escherichia coli bacteremia in a patient with acute myeloid leukemia: A case report and a literature review about E. coli-induced Ecthyma gangrenosum. Iranian Journal of Clinical Infectious Diseases 14: No. 3, Jun 2019. Available from: URL: http://doi.org/10.5812/archcid.66413 -Iran Salehi M, et al. Ecthyma gangrenosum due to escherichia coli bacteremia in a patient with acute myeloid leukemia: A case report and a literature review about E. coli-induced Ecthyma gangrenosum. Iranian Journal of Clinical Infectious Diseases 14: No. 3, Jun 2019. Available from: URL: http://​doi.​org/​10.​5812/​archcid.​66413 -Iran
Metadaten
Titel
Cytarabine/daunorubicin
Ecthyma gangernusom secondary to Escherichia coli bacteraemia: case report
Publikationsdatum
01.09.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-67163-0

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Cinacalcet

Case report

Tetryzoline

Case report

Bupivacaine

Case report

Vandetanib